Literature DB >> 24793972

Synthesis, pharmacological characterization, and structure-activity relationship studies of small molecular agonists for the orphan GPR88 receptor.

Chunyang Jin1, Ann M Decker, Xi-Ping Huang, Brian P Gilmour, Bruce E Blough, Bryan L Roth, Yang Hu, Joseph B Gill, X Peter Zhang.   

Abstract

GPR88 is an orphan G-protein-coupled receptor (GPCR) enriched in the striatum. Genetic deletion and gene expression studies have suggested that GPR88 plays an important role in the regulation of striatal functions and is implicated in psychiatric disorders. The signal transduction pathway and receptor functions of GPR88, however, are still largely unknown due to the lack of endogenous and synthetic ligands. In this paper, we report the synthesis of a GPR88 agonist 2-PCCA and its pure diastereomers, which were functionally characterized in both transiently and stably expressing GPR88 HEK293 cells. 2-PCCA inhibited isoproterenol-stimulated cAMP accumulation in a concentration-dependent manner in cells expressing GPR88 but not in the control cells, suggesting that the observed cAMP inhibition is mediated through GPR88 and that GPR88 is coupled to Gαi. 2-PCCA did not induce calcium mobilization in GPR88 cells, indicating no Gαq-mediated response. A structure-activity relationship (SAR) study of 2-PCCA was also conducted to explore the key structural features for GPR88 agonist activity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24793972      PMCID: PMC4102971          DOI: 10.1021/cn500082p

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  22 in total

1.  GPR88 - a putative signaling molecule predominantly expressed in the striatum: Cellular localization and developmental regulation.

Authors:  Vincent Van Waes; Kuei Y Tseng; Heinz Steiner
Journal:  Basal Ganglia       Date:  2011-07-01

2.  Regulation of gene expression by lithium and depletion of inositol in slices of adult rat cortex.

Authors:  Philip E Brandish; Ming Su; Daniel J Holder; Paul Hodor; John Szumiloski; Robert R Kleinhanz; Jaime E Forbes; Mollie E McWhorter; Sven J Duenwald; Mark L Parrish; Sang Na; Yuan Liu; Robert L Phillips; John J Renger; Sethu Sankaranarayanan; Adam J Simon; Edward M Scolnick
Journal:  Neuron       Date:  2005-03-24       Impact factor: 17.173

3.  Region-specific transcriptional changes following the three antidepressant treatments electro convulsive therapy, sleep deprivation and fluoxetine.

Authors:  B Conti; R Maier; A M Barr; M C Morale; X Lu; P P Sanna; G Bilbe; D Hoyer; T Bartfai
Journal:  Mol Psychiatry       Date:  2006-10-10       Impact factor: 15.992

4.  Probes for narcotic receptor mediated phenomena. 41. Unusual inverse μ-agonists and potent μ-opioid antagonists by modification of the N-substituent in enantiomeric 5-(3-hydroxyphenyl)morphans.

Authors:  Kejun Cheng; Yong Sok Lee; Richard B Rothman; Christina M Dersch; Ross W Bittman; Arthur E Jacobson; Kenner C Rice
Journal:  J Med Chem       Date:  2011-01-19       Impact factor: 7.446

5.  Mu-opioid receptor activation induces transcriptional plasticity in the central extended amygdala.

Authors:  K Befort; D Filliol; A Ghate; E Darcq; A Matifas; J Muller; A Lardenois; C Thibault; D Dembele; J Le Merrer; J A J Becker; O Poch; B L Kieffer
Journal:  Eur J Neurosci       Date:  2008-06       Impact factor: 3.386

6.  Asymmetric cyclopropanation of styrenes catalyzed by metal complexes of D2-symmetrical chiral porphyrin: superiority of cobalt over iron.

Authors:  Ying Chen; X Peter Zhang
Journal:  J Org Chem       Date:  2007-06-23       Impact factor: 4.354

7.  Striatal GPR88 expression is confined to the whole projection neuron population and is regulated by dopaminergic and glutamatergic afferents.

Authors:  Renaud Massart; Jean-Philippe Guilloux; Virginie Mignon; Pierre Sokoloff; Jorge Diaz
Journal:  Eur J Neurosci       Date:  2009-07-28       Impact factor: 3.386

8.  New twist on orphan receptor GPR88 function.

Authors:  David M Lovinger
Journal:  Nat Neurosci       Date:  2012-11       Impact factor: 24.884

9.  Effect of MK-801 on gene expressions in the amygdala of rats.

Authors:  Tadasu Matsuoka; Masahiko Tsunoda; Tomiki Sumiyoshi; Ichiro Takasaki; Yoshiaki Tabuchi; Tomonori Seo; Kodai Tanaka; Takashi Uehara; Hiroko Itoh; Michio Suzuki; Masayoshi Kurachi
Journal:  Synapse       Date:  2008-01       Impact factor: 2.562

10.  Automated design of ligands to polypharmacological profiles.

Authors:  Jérémy Besnard; Gian Filippo Ruda; Vincent Setola; Keren Abecassis; Ramona M Rodriguiz; Xi-Ping Huang; Suzanne Norval; Maria F Sassano; Antony I Shin; Lauren A Webster; Frederick R C Simeons; Laste Stojanovski; Annik Prat; Nabil G Seidah; Daniel B Constam; G Richard Bickerton; Kevin D Read; William C Wetsel; Ian H Gilbert; Bryan L Roth; Andrew L Hopkins
Journal:  Nature       Date:  2012-12-13       Impact factor: 49.962

View more
  20 in total

Review 1.  Integrated Approaches for Genome-wide Interrogation of the Druggable Non-olfactory G Protein-coupled Receptor Superfamily.

Authors:  Bryan L Roth; Wesley K Kroeze
Journal:  J Biol Chem       Date:  2015-06-22       Impact factor: 5.157

2.  Mice Lacking GPR88 Show Motor Deficit, Improved Spatial Learning, and Low Anxiety Reversed by Delta Opioid Antagonist.

Authors:  Aura C Meirsman; Julie Le Merrer; Lucie P Pellissier; Jorge Diaz; Daniel Clesse; Brigitte L Kieffer; Jérôme A J Becker
Journal:  Biol Psychiatry       Date:  2015-06-06       Impact factor: 13.382

3.  Effect of Substitution on the Aniline Moiety of the GPR88 Agonist 2-PCCA: Synthesis, Structure-Activity Relationships, and Molecular Modeling Studies.

Authors:  Chunyang Jin; Ann M Decker; Danni L Harris; Bruce E Blough
Journal:  ACS Chem Neurosci       Date:  2016-08-16       Impact factor: 4.418

4.  Toward the next step in G protein-coupled receptor research: a knowledge-driven analysis for the next potential targets in drug discovery.

Authors:  Koji Nagata; Yukie Katayama; Tomomi Sato; Yeondae Kwon; Takeshi Kawabata
Journal:  J Struct Funct Genomics       Date:  2017-01-06

Review 5.  Hunting for the function of orphan GPCRs - beyond the search for the endogenous ligand.

Authors:  Raise Ahmad; Stefanie Wojciech; Ralf Jockers
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

Review 6.  Neuro-psychopharmacological perspective of Orphan receptors of Rhodopsin (class A) family of G protein-coupled receptors.

Authors:  Muhammad Zahid Khan; Ling He
Journal:  Psychopharmacology (Berl)       Date:  2017-03-13       Impact factor: 4.530

Review 7.  Orphan Receptor GPR88 as an Emerging Neurotherapeutic Target.

Authors:  Na Ye; Bang Li; Qi Mao; Eric A Wold; Sheng Tian; John A Allen; Jia Zhou
Journal:  ACS Chem Neurosci       Date:  2018-12-20       Impact factor: 4.418

8.  Design, Synthesis, and Structure-Activity Relationship Studies of (4-Alkoxyphenyl)glycinamides and Bioisosteric 1,3,4-Oxadiazoles as GPR88 Agonists.

Authors:  Md Toufiqur Rahman; Ann M Decker; Tiffany L Langston; Kelly M Mathews; Lucas Laudermilk; Rangan Maitra; Weiya Ma; Emmanuel Darcq; Brigitte L Kieffer; Chunyang Jin
Journal:  J Med Chem       Date:  2020-11-18       Impact factor: 7.446

9.  Mapping GPR88-Venus illuminates a novel role for GPR88 in sensory processing.

Authors:  Aliza T Ehrlich; Meriem Semache; Julie Bailly; Stefan Wojcik; Tanzil M Arefin; Christine Colley; Christian Le Gouill; Florence Gross; Viktoriya Lukasheva; Mireille Hogue; Emmanuel Darcq; Laura-Adela Harsan; Michel Bouvier; Brigitte L Kieffer
Journal:  Brain Struct Funct       Date:  2017-11-06       Impact factor: 3.270

10.  Increased Alcohol Seeking in Mice Lacking Gpr88 Involves Dysfunctional Mesocorticolimbic Networks.

Authors:  Sami Ben Hamida; Sueli Mendonça-Netto; Tanzil Mahmud Arefin; Md Taufiq Nasseef; Laura-Joy Boulos; Michael McNicholas; Aliza Toby Ehrlich; Eleanor Clarke; Luc Moquin; Alain Gratton; Emmanuel Darcq; Laura Adela Harsan; Rafael Maldonado; Brigitte Lina Kieffer
Journal:  Biol Psychiatry       Date:  2018-02-09       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.